OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-27.9%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$109M
AUM Growth
+$109M
(-39%)
Cap. Flow
-$21.5M
Cap. Flow
% of AUM
-19.73%
Top 10 Holdings %
Top 10 Hldgs %
99.01%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$21.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Replimune Group
REPL
$422M
| $51.4M | 47.17% | 3,001,319 | – | – |
|
2
Nuvation Bio
NUVB
$1.02B
| $20.2M | 18.55% | 15,072,340 | – | – |
|
|
IMA
3
ImageneBio, Inc. Common Stock
IMA
$150M
| $9.74M | 8.94% | 2,249,123 | – | – |
|
|
MORF
4
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.1M | 6.52% | 309,846 | – | – |
|
|
KRON
5
DELISTED
Kronos Bio
KRON
| $4.96M | 4.56% | 3,818,283 | – | – |
|
|
SPRB
6
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $4.88M | 4.49% | 2,161,022 | – | – |
|
7
Sana Biotechnology
SANA
$777M
| $3.27M | 3% | 843,750 | – | – |
|
8
Immunic
IMUX
$80.9M
| $2.63M | 2.41% | 1,788,160 | – | – |
|
|
THRX
9
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.91M | 1.76% | 711,479 | – | – |
|
|
ALPN
10
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.76M | 1.62% | 153,700 -1,875,880 | -92% | -$21.5M |
|
|
SYRS
11
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $993K | 0.91% | 251,270 | – | – |
|
12
Senti Biosciences
SNTI
$38.5M
| $80.9K | 0.07% | 195,792 | – | – |
|